8:17am PDT - June 5th, 2023

RT @TiansterZhang: Phase 3 #THOR trial reading out means erdafitinib is the RIGHT life extending option for patients with #FGFR alterations…

0 retweets   2 likes  - Paulo G Bergerot (@PauloBergerot)